Humedica, Pfizer Inc. Collaborate for Data-Driven Research

BOSTON & NEW YORK--(BUSINESS WIRE)-- Humedica, Inc. and Pfizer Inc. (PFE) today announced a multi-year strategic alliance to jointly advance capabilities to derive insights from real world data.Hu…

---

Stunning Data for Ambit Biosciences/Astellas Pharma Inc. AML Drug

The promise shown by Ambit Biosciences' quizartinib, which is partnered with Astellas, as a treatment for acute myeloid leukaemia, has caused a stir at the American Society of Hematology meeting in At…

---

Seattle Genetics, Inc. Highlights Data Presentations From Genentech ADC Collaborator Programs at American Society of Hematology Annual Meeting

ATLANTA--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today highlighted clinical data from two antibody-drug conjugate (ADC) programs in development by Genentech, a member of the Roche Group…

---

Astellas Pharma Inc. Release: New Phase II Data Demonstrates Significant Activity of Quizartinib in Relapsed or Refractory AML Patients

ATLANTA--(BUSINESS WIRE)--Astellas Pharma Inc. (Tokyo: 4503, Astellas) and Ambit Biosciences Corporation today announced the results from a completed phase II study with the investigational FLT3 inhib…

---